OAM
TMO icon

Ostrum Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Ostrum Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Sell
625
-4,094
-87% -$2.22M 0.02% 421
2025
Q4 		$2.73M Sell
4,719
-4,833
-51% -$2.73M 0.13% 126
2025
Q3 		$4.63M Buy
9,552
+1,278
+15% +$595K 0.21% 79
2025
Q2 		$3.35M Sell
8,274
-360
-4% -$151K 0.16% 115
2025
Q1 		$4.3M Buy
8,634
+444
+5% +$240K 0.23% 79
2024
Q4 		$4.26M Buy
8,190
+1,285
+19% +$706K 0.37% 58
2024
Q3 		$4.27M Sell
6,905
-4,254
-38% -$2.52M 0.35% 58
2024
Q2 		$6.17M Sell
11,159
-1,093
-9% -$626K 0.54% 29
2024
Q1 		$7.12M Sell
12,252
-221
-2% -$124K 0.56% 22
2023
Q4 		$6.62M Sell
12,473
-3,996
-24% -$1.93M 0.58% 25
2023
Q3 		$8.34M Sell
16,469
-790
-5% -$421K 0.77% 10
2023
Q2 		$9M Buy
17,259
+585
+4% +$316K 0.75% 8
2023
Q1 		$9.61M Buy
+16,674
New +$9.4M 0.84% 7
2019
Q3 		– Sell
-23,250
Closed -$6.83M – 129
2019
Q2 		$6.83M Buy
23,250
+6,810
+41% +$1.88M 1.89% 12
2019
Q1 		$4.5M Buy
16,440
+1,990
+14% +$495K 1.47% 14
2018
Q4 		$3.23M Buy
+14,450
New +$3.39M 1.27% 14

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ostrum Asset Management's TMO Position: Q1 2026 in Review

Ostrum Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 87% in Q1 2026, selling an estimated $2.22M and leaving 625 shares worth $307K. The position accounts for 0.02% of the portfolio, ranked #421.

Ostrum Asset Management first reported a position in TMO in Q4 2018 and has held it in 16 quarters since. The position peaked at $9.61M in Q1 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Ostrum Asset Management held 625 shares of Thermo Fisher Scientific worth $307K as of Q1 2026.
  • Ostrum Asset Management sold 4,094 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.22M.
  • Thermo Fisher Scientific made up 0.02% of Ostrum Asset Management's portfolio in Q1 2026, its #421 holding.
  • Ostrum Asset Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 16 quarters since.
  • Ostrum Asset Management's Thermo Fisher Scientific position peaked at $9.61M in Q1 2023.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.